A 2-year Study of Patients With Schizophrenia Who Are Treated With Long-acting Injectable Risperidone.

NCT00261430 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
650
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Janssen, LP